Here we are in the last week of June, and what a busy month it has been. We kicked off the month with a face-to-face meeting in DC with CMMI, where ESCO participants joined Next Gen ACO participants … [Read more...]
June and the QPP
Print This Post
Print This Post
The Measure of Patient Engagement
Print This Post
Do you believe in left- and right-brain dominance theory? In popular culture, left-brain thinkers excel in math and logic and right-brain thinkers are more creative and visual. Left-brain folks are … [Read more...]
MIPS Group Reporting: Better Together or on Your Own?
Print This Post
As if the Merit-based Incentive Payment System (MIPS) wasn’t complicated enough, here I am to further complicate things! (You’re welcome!) All kidding aside, I'm going to focus on the area in MIPS … [Read more...]
Nephrology News Roundup
Print This Post
Here’s a roundup of nephrology news over the past couple weeks. Click on the headlines to browse the articles. Or, if you’ve discovered other newsworthy items that may be of interest to our team or … [Read more...]
MACRA: The Lesser of 2 Evils?
Print This Post
A few weeks ago, I had the privilege of attending our annual Fresenius Medical Care Medical Directors meeting. The meeting was well attended and the participants were actively engaged. The MACRA … [Read more...]
Data Insights: Emerging Emojis
Print This Post
This past Mother’s Day I received lots of flowers and love in text messages: Happy Mother’s Day! I hope you are having a relaxing day Happy Mother’s Day to you Love to you on Mother’s … [Read more...]
Quality – The Importance of Measure Selection
Print This Post
Last week, I received a call from a nephrologist who works at a small practice. Let’s just call him Dr. Smith for anonymity. The call went something like this… Dr. Smith: “Diana, I am looking at my … [Read more...]
Intravenous Form of Sensipar® Has Been Approved by the FDA
Print This Post
Parsabiv™ (etelcalcetide), an IV formulation similar to the oral calcimimetic Sensipar® (cinicalset), was recently approved by the U.S. Food and Drug Administration to treat secondary … [Read more...]
